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Temporomandibular disorders (TMD) are characterized by the presence of temporomandibular joint (TMJ) and/or masticatory muscle pain and dysfunction. 
Low-level laser is presented as an adjuvant therapeutic modality for the treatment of 
TMD, especially when the presence of inflammatory pain is suspected. Objective: To 
systematically review studies that investigated the effect of low level laser therapy (LLLT) 
on the pain levels in individuals with TMD. Material and Methods: The databases Scopus, 
embase, ebsco and PubMed were reviewed from January/2003 to October/2010 with 
the following keywords: laser therapy, low-level laser therapy, temporomandibular joint 
disorders, temporomandibular joint dysfunction syndrome, temporomandibular joint, 
temporomandibular, facial pain and arthralgia, with the inclusion criteria for intervention 
studies in humans. exclusion criteria adopted were intervention studies in animals, studies 
that were not written in english, Spanish or Portuguese, theses, monographs, and abstracts 
presented in scientific events. Results: After a careful review, 14 studies fit the criteria 
for inclusion, of which, 12 used a placebo group. As for the protocol for laser application, 
the energy density used ranged from 0.9 to 105 J/cm², while the power density ranged 
from 9.8 to 500 mW. The number of sessions varied from 1 to 20 and the frequency of 
applications ranged from daily for 10 days to 1 time per week for 4 weeks. A reduction in 
pain levels was reported in 13 studies, with 9 of these occurring only in the experimental 
group, and 4 studies reporting pain relief for both the experimental group and for the 
placebo. Conclusion: Most papers showed that LLLT seemed to be effective in reducing pain 
from TMD. However, the heterogeneity of the standardization regarding the parameters 
of laser calls for caution in interpretation of these results. Thus, it is necessary to conduct 
further research in order to obtain a consensus regarding the best application protocol for 
pain relief in patients with TMD.
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INTRODUCTION
Temporomandibular disorders (TMD) is 
considered the most common cause of pain of 
non-dental origin25 in the orofacial region and 
encompasses a heterogeneous group of disorders 
with common features of psychophysiological 
orofacial pain, masticatory dysfunction, or both30.
Signs and symptoms of this dysfunction are 
present in 86% of the population, most frequently 
in women in the 30 year-old age group5. The 
prevalence of TMD (or symptoms suggestive of 
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TMD) varies from 21.5% to 51.8%4,12,17,34. 
Among the several reported signs and symptoms 
of TMD, pain has, with no doubt, most debilitating 
and unbearable effect on the patient’s life. It has 
been found that masticatory muscle pain is the chief 
complaint of patients with TMD, usually associated 
with tension and fatigue, ranging from mild 
sensitivity to extreme discomfort, and frequently 
worsened by function of the muscles involved12,17.
Contemporary orofacial pain concepts aim to 
prevent, cure, or alleviate signs and symptoms 
of pain morbidity, as well as to reduce their 
impact on the patient´s quality of life. Because 
of TMD’s multifactorial etiology and variety of 
clinical presentations, the treatment of this 
disorder is extensive and diverse, involving 
professionals from different areas and includes 
several therapies: low level laser therapy8,19,27, 
acupuncture22, transcutaneous electrical nerve 
stimulation (TeNS)32, ultrasound15, massage2, 
pharmacotherapy24, use of occlusal splints28, and 
psychological treatment, among others.
The use of laser photobiomodulation to reduce 
TMD pain and promote anti-inflammatory effects 
has been of great interest in the recent literature. 
Currently, its classification is based on the interaction 
of laser with the target tissue in question. The term 
LLLT is used when working in compliance with the 
threshold of cell survival3. Karu18 (2001) stated that 
this is a non-thermal therapy that can promote cell 
and tissue alterations caused by different types of 
metabolic activation, such as: increased activity in 
the mitochondria and Na(+)/K(+) pump, increased 
vascularization and the formation of fibroblasts, 
resulting in an increase in the recovery process and/
or tissue healing with non-invasive characteristics.
The use of laser has grown in all areas of 
dentistry especially for conditions such as TMD 
that involves obtaining analgesia and reducing 
inflammation. In general, patients are receptive to 
LLLT which also has a positive psychological effect 
especially in chronic patients31. The therapeutic 
properties of lasers, such as tissue repair, mediation 
of inflammatory processes, and analgesia in acute 
and chronic pain as well as improvement of local 
microcirculation have been proven by several 
authors31.
Based on that, the aim of this study is to perform 
a systematic review of the effect of LLLT in the 
control of pain in patients with TMD.
MATERIAL AND METhODS
Search strategy and inclusion criteria
A literature search was performed to identify 
interventional studies involving the application of 
LLLT in patients with painful symptoms caused by 
TMD. The databases Scopus, embase, ebsco, and 
PubMed were revised from January 2003 to October 
2010. Results of previous studies on the same 
subject were already summarized and reported in 
a previous publication3. 
The keywords laser therapy, low level laser 
therapy, temporomandibular joint disorders, 
temporomandibular joint dysfunction syndrome, 
temporomandibular joint, temporomandibular, 
facial pain, and arthralgia, were used either as 
MeSH (Medical Subject Headings is the NLM 
controlled vocabulary thesaurus used for indexing 
papers for PubMed) terms or as free-text in different 
combinations. We resorted to the logical operator 
“AND” to combine descriptors and terms used to 
trace publications. In the present study were only 
considered papers that used theses descriptors.
Two authors independently screened titles and 
abstracts for potential eligibility and the full texts 
for the final eligibility. The data were extracted 
using a standardized data collection form to record 
study design and methodological features, patient 
characteristics, interventions, outcomes, and 
missing outcome data. We chose not to include 
theses, monographs, and abstracts presented in 
events because the conducting of such a systematic 
search of the same is logistically unfeasible. Studies 
that focused on intervention in animals and those 
that were not written in english, Portuguese or 
Spanish were excluded.
The papers that met the inclusion criteria were 
carefully examined for the extraction of data, 
such as: study setting, including site and sample, 
age range, methods of diagnosis of TMD and pain 
assessment, sites of laser application, laser type, 
manufacturer, dose, application time, frequency or 
number of sessions per week, and pain outcomes.
RESULTS
The results are described in the following 
sequence (Figure 1): 
- progressive selection of the studies and the 
Figure 1- Flowchart of the selection phases of the study
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number of items in each stage,
- characteristics of the sample from each study,
- parameters used for the LLLT in each study.
At the end of paper selection process, only 14 
met the specific inclusion criteria, being seven from 
Brazil (studies 2, 6, 7, 8, 12, 13, 14), one from Peru 
(study 1), one from Turkey (study 3), one from the 
Czech Republic (study 4), one from Cuba (study 5), 
two from Iran (studies 9, 11), and one from Austria 
(study 10) (Figure 2). The number of patients 
involved in the intervention process ranged from 
fourteen [8] to eighty [4] per group (Figure 2). In 
all the studies in this systematic review, there was 
a higher prevalence of women compared to men.
The results showed that, from the 14 selected 
studies, 12 (1, 2, 3, 4, 6, 7, 8, 9, 10, 11, 13, 14) 
included a placebo control group, while one (5) 
compared the intervention with laser to that with 
pharmacology and did not include a placebo group, 
and one study (12) evaluated only the experimental 
group (Figure 2).
Regarding the methods used for the diagnosis of 
TMD, 4 studies (3, 4, 10, 14) used the diagnostic 
criteria for TMD proposed by the “Research 
Diagnostic Criteria” (RDC/TMD). Most studies (1, 2, 
7, 9, 10, 11, 12, 13, 14) only evaluated the signs 
and symptoms of TMD, quantifying pain by the 
Visual Analogue Scale (VAS) (Figure 2).
Some studies, in addition to performing the 
TMD diagnosis and assessment of pain intensity, 
made use of additional tests of the masticatory 
function, such as electromyographic evaluation 
(14), pressure pain threshold determination (2), 
and chewing efficiency (8) (Figure 2).
In terms of sites of laser application, seven 
studies (1, 3, 4, 7, 9, 12, 13) beamed the laser 
into the joint and/or the affected muscles. Three 
others (6, 8, 10) applied the laser only at the TMJ. 
Laser irradiation only in the affected muscles was 
performed in two studies (11,14), while one study 
performed applications at acupuncture points 
as well as the TMJ (5) (Figure 3). Moreover, it is 
noteworthy that seven studies (1, 3, 7, 11, 12, 13, 
14) made application of laser light at the points of 
greatest pain of the patient, and the rest of the 
works irradiated pre-established points, whether 
or not they were points of greatest pain.
In relation to the wavelengths used in the 
studies, it was found that six (1, 3, 4, 7, 9, 13) 
conducted applications in the infrared range, 5 (2, 
6, 8, 10, 14) used the red wavelength, 2 studies 
(11, 12) did a combination of red and infrared, and 
one study (5) did not specify the wavelength used 
(Figure 3).
The energy and power density settings, time 
of laser application, frequency and number of 
sessions, and periods of re-evaluation/follow-up 
are shown in Figure 3. A great variability in the 
parameters utilized can be seen. The energy density 
used in the studies ranged from 0.9 J/cm² to 105 
J/cm², and the power density ranged from 9.8 mW 
to 500 mW. In relation to application time, some 
studies suggest the amount of total elapsed time 
applied to all points in a session, while others seem 
to inform the time applied to each point; however, 
this information was not clear in the papers. It is 
noteworthy that there was insufficient information 
for the items covered in this paragraph in some 
studies, as seen in Figure 3.
The number of sessions of laser applications 
varied from one session (13) to twenty (10), as well 
as the frequency of applications ranging from daily 
for 10 consecutive days (5) to 1 time per week for 
4 consecutive weeks (7). The re-evaluation periods 
ranged from 1 week (11, 13) to 12 months after 
the last application (9) (Figure 3).
The effectiveness of laser photobiomodulation 
is shown in Figure 3. It can be noted that only 
one study (10) observed that, at the end, both 
placebo and treatment groups that received laser 
intervention had shown pain in the TMJ during 
mandibular function. The other studies showed 
a reduction of pain after the end of the laser 
photobiomodulation sessions, of which in 9 (3, 4, 5, 
6, 8, 9, 12, 13, 14) pain was significantly reduced 
only in the group receiving laser intervention, and in 
4 (1, 2, 7, 11) relief of painful symptoms occurred 
in both the laser and placebo groups.
DISCUSSION
Musculoskeletal condition, like TMD are the 
major cause of non-dental pain in the orofacial 
region24. epidemiological studies estimate that 40% 
to 75% of the population, have at least one sign of 
TMD, while 33% have at least one symptom such as 
facial or TMJ pain13. Currently, it is disturbing to see 
the number of patients with TMD treated with non-
evidence-based therapies6, often without competent 
professional assistance37. As an alternative therapy, 
LLLT with its analgesic, anti-inflammatory, anti-
edematous, and biostimulatory effects has proven 
to be effective in reducing pain and muscle tension 
in patients with TMD7,9,16,21,23,26,35,38. 
LLLT is considered a safe therapeutic 
procedure, with well-established indications and 
contraindications well established through positive 
clinical trials, scientific investigations of the tissue 
changes that it promotes, and above all a better 
understanding of its mechanism of action29.
In 2004, the World Association of Laser Therapy 
approved an agreement on the format of clinical 
studies with LLLT for muscle and joint pain. This 
document established the mandatory presence 
of a placebo group as part of the study design. 
Corroborating these guidelines, this review found 
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that the majority of studies used a placebo group, 
except for the work done by Carvalho, et al.8 
(2010), who only used the experimental group that 
received the LLLT, and León, Almagro and García23 
(2007), who compared the group that received 
laser intervention with another that received 
pharmacological treatment. 
There still no consensus on the way TMD 
diagnosis and measurement of the presence 
and severity of pain is used by researchers and 
clinicians. For diagnosis of individual cases, a 
detailed history is still the most important procedure 
in formulating the initial diagnostic impression. 
Physical examination, consisting of muscle and TMD 
palpation, measurement of mandibular active range 
of motion, and joint noise analysis, when performed 
by trained professionals, are important steps in 
the diagnosis and formulation of management 
strategies, as well as in monitoring the effectiveness 
of proposed treatments13. Accordingly, in this review 
it was found that only four studies9,14,16,38 diagnosed 
TMD according to the criteria proposed by the 
Research Diagnostic Criteria for Temporomandibular 
Disorders, with are widely used for diagnosis of 
TMD. However, none of these identified the severity 
of TMD in their patients which is of paramount 
importance since TMD may also be present in 
a sub-clinical form. As can be observed in the 
papers included in the present review, there are no 
standardization of the diagnostic criteria, which is 
a limitation of most of systematic reviews involving 
musculoskeletal conditions as TMD.
Studies using auxiliary methods of diagnosis, 
as Shirani, et al.36 (2009), who made use of 
computerized tomography and magnetic resonance 
imaging of the TMJ, and Venancio, Camparis and 
Lizarelli37 (2005); Mazzetto, et al.26 (2007); and 
Carrasco, et al.7 (2008), who used panoramic 
radiography, should be analyzed with caution 
because there is not always a direct association 
between the findings of such examinations and the 
presence of signs and symptoms of TMD1,33.
The use of LLLT for musculoskeletal disorders 
is based on the irradiation of some specific and 
interrelated areas: the painful area, trigger-
points and the area of referred pain as well as in 
acupuncture points. With this in mind, the studies of 
Kulekcioglu, et al.20 (2003); Çetiner, Kahraman and 
Yücetaş9 (2006); Fikácková, et al.16 (2007); Cunha, 
et al.11 (2008); Santos, et al.35 (2010); and Carvalho, 
et al.8 (2010) did irradiation on the affected area 
and on areas of referred pain, according to patient 
symptoms. In contrast, Mazzetto, et al.26 (2007), 
Carrasco, et al.7 (2008), and emshoff, et al.14 
(2008) only performed the application at the TMJ. 
Shirani, et al.39 (2009) and Venezian, et al.38 (2010) 
made the application only in the muscle region; 
and León, Almagro and García23 (2007) made the 
application on acupuncture points: gallbladder, 
stomach, and TMJ. Furthermore, it is useful to 
remind that the antiinflammatory and analgesic 
effects of laser light occur only in the affected tissue, 
which explains the importance of muscle and joint 
palpation for the identification of points causing the 
patient’s pain. Based on this context, only seven 
studies9,11,13,19,24,38,42 established laser application at 
the point of greatest pain, while the rest made the 
application on pre-established points.
Lasers with an infrared wavelength are the most 
suitable due to their greater penetration. The most 
commonly used are located in the electromagnetic 
spectrum from 780 to 904 nm37. The findings of 
Kulekcioglu, et al.20 (2003); Venancio, Camparis and 
Lizarelli37 (2005); Çetiner, Kahraman and Yücetaş9 
(2006); Fikácková, et al.16 (2007); Mazzetto, et 
al.26 (2007); Carrasco, et al.7 (2008); Cunha, et 
al.11 (2008); Lassemi, et al.21 (2008); Santos, et al.35 
(2010); and Venezian, et al.38 (2010) corroborate 
the above data using wavelengths in the infrared 
range, whose electromagnetic spectra varied from 
780 nm to 980 nm. In contrast, emshoff, et al.14 
(2008) did not corroborate with the above authors 
and used a wavelength in the red range. However, 
Carvalho, et al.8 (2010) performed a combination 
of the two wavelengths, red and infrared.
The efficacy of adjuvant therapy has been 
proven by several studies as cited above. However, 
the interaction of laser light with tissue can lead 
to different results. These results depend on 
several factors such as the wavelength, energy 
density, and power density, as well as the optical 
properties of tissue39. Therefore, many studies 
have been conducted in order to reach a consensus 
on the intensity, exposure time, and site of laser 
application10. 
In terms of frequency and number of laser 
sessions applied, Mazzetto, et al.26 (2007), Carrasco, 
et al.7 (2008), and Venezian, et al.38 (2010) argued 
for eight sessions with applications twice per 
week. Venancio, Camparis and Lizarelli37 (2005) 
and Shirani, et al.36 (2009) established the use of 
six sessions with a frequency of twice per week. 
Çetiner, Kahraman and Yücetaş9 (2006); Fikácková, 
et al.16 (2007); and León, Almagro and García23 
(2007) argued for 10 sessions; however, each one 
established different application frequencies.
Studies that have shown the greatest laser 
photobiomodulation effectiveness appear to be 
linked to higher irradiation protocols (energy 
density and/or power density) as well as to a greater 
number of sessions and frequency of application. 
It was also noted that, of the eight studies that 
showed the best results, four applied laser to the 
points of greatest pain, whether joint or muscle, 
while the other four applied laser to pre-established 
points. 
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The studies of Çetiner, Kahraman and Yücetaş9 
(2006); Mazzetto, et al.26 (2007); and Venezian, et 
al.38 (2010) did a follow-up of patients 30 days after 
the last irradiation. Çetiner, Kahraman and Yücetaş9 
(2006) and Venezian, et al.38 (2010) found that pain 
reduction remained statistically significant during 
this period, while Mazzetto, et al.26 (2007) found 
that the least tenderness to palpation was seen at 
the last session of laser application. Lassemi, et al.21 
(2008) followed patients for 2 years and observed 
significant results for both pain reduction and for 
clicking. Although most studies of this review did 
not make use of a patient follow-up period, it may 
be suggested that for those who carried out the 
follow-up, the laser applications promoted a relief 
of painful symptomatology for at least 30 days after 
the last irradiation.
As can be seen here, there is still no consensus 
on the best parameters and standards of laser 
photobiomodulation and, therefore, the definition 
of the best treatment protocol and clinical 
recommendation to be used in cases of TMD pain 
is not possible at the present time.
However, it seems clear that the use of 
laser brings benefits when properly applied and 
administered, although the exact mechanism of 
action is still to be defined. In some studies, it 
was noted that the results of LLLT were minimum 
possibly due to the absence of a specific protocol. 
This difficulty in the establishment of specific 
irradiation parameters for a particular area is also 
observed in other fields such as physical therapy 
and medicine, for example. Recently, for the area 
of physical therapy, specific guidelines have been 
published and studies are being performed to test 
the efficacy of LLLT. Therefore, it is imperative to 
also draw up specific guidelines for dentistry, as its 
applicability in this area is extensive, widespread, 
and extremely important for the control of pain 
and/or inflammation of the masticatory muscles 
and temporomandibular joint.
In short, the results allow us to suggest that 
the effectiveness of LLLT is more accentuated when 
using the laser in wavelengths in the infrared region 
of light spectrum, as well as with higher irradiation 
protocols (energy density and/or power density) 
and a larger number of sessions and frequency of 
application.
CONCLUSION
Most papers, including those using a double-
blind and placebo-controlled trial, showed that 
LLLT seemed to be effective in reducing pain 
from TMD. However, the heterogeneity of the 
standardization regarding the parameters of laser 
calls for caution in interpretation of these results. A 
potential explanation for the LLLT positive results in 
reducing pain levels could be a dose-specific anti-
inflammatory, healing and analgesic effect in TMJ 
as well as in the masticatory muscle painful area. 
However, more studies are needed to precisely 
determine optimal treatment procedures and 
parameters for LLLT in TMD.
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